Improved Protection from Primary Ocular HSV-1 Infection and Establishment of Latency Using Multigenic DNA Vaccines-Reference-Cited by-同舟云学术

Improved Protection from Primary Ocular HSV-1 Infection and Establishment of Latency Using Multigenic DNA Vaccines

Published:2004-02-01 Issue:2 Volume:45 Page:506
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Osorio Yanira¹,Cohen Jacob¹,Ghiasi Homayon²

Affiliation:

1. From the Center for Neurobiology and Vaccine Development, Ophthalmology Research, Department of Surgery, Cedars-Sinai Medical Center Burns and Allen Research Institute, Los Angeles, California; and the

2. From the Center for Neurobiology and Vaccine Development, Ophthalmology Research, Department of Surgery, Cedars-Sinai Medical Center Burns and Allen Research Institute, Los Angeles, California; and the2Department of Ophthalmology, University of California

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Binding of herpesvirus entry mediator (HVEM) and HSV-1 gD affect reactivation but not latency levels;PLOS Pathogens;2023-09-22

2. Corneal gene therapy: Structural and mechanistic understanding;The Ocular Surface;2023-07

3. Herpes Simplex Virus 1 Glycoproteins Differentially Regulate the Activity of Costimulatory Molecules and T Cells;mSphere;2022-10-26

4. Healing of Ocular Herpetic Disease Following Treatment With an Engineered FGF-1 Is Associated With Increased Corneal Anti-Inflammatory M2 Macrophages;Frontiers in Immunology;2021-05-13

5. Gene therapy in the anterior eye segment;Current Gene Therapy;2021-04-23